Once the pathway was activated, the expression of target genes such as CTGF, Bcl-2, and CyclinB1 could be inhibited, which in turn strengthened the radiosensitivity in ESCC. This evidence concerns the gene BCL2 and esophageal squamous cell carcinoma.